gptkbp:instanceOf
|
gptkb:drug
neuromuscular-blocking drug
aminosteroid
|
gptkbp:antidote
|
gptkb:neostigmine
gptkb:sugammadex
|
gptkbp:approvedBy
|
1984
|
gptkbp:ATCCode
|
gptkb:M03AC03
|
gptkbp:CASNumber
|
50700-72-6
|
gptkbp:category
|
muscle relaxant
general anesthetic adjunct
|
gptkbp:discoveredBy
|
gptkb:Organon
|
gptkbp:eliminationHalfLife
|
60–80 minutes
|
gptkbp:excretion
|
urine
bile
|
gptkbp:hasMolecularFormula
|
C34H57BrN2O4
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vecuronium bromide
|
gptkbp:legalStatus
|
prescription only
|
gptkbp:mechanismOfAction
|
competitive antagonist of acetylcholine at nicotinic receptors
|
gptkbp:metabolism
|
liver
|
gptkbp:pregnancyCategory
|
C (US)
|
gptkbp:proteinBinding
|
60–80%
|
gptkbp:PubChem_CID
|
DB01339
444041
|
gptkbp:routeOfAdministration
|
intravenous
|
gptkbp:sideEffect
|
allergic reaction
hypotension
prolonged paralysis
|
gptkbp:synonym
|
gptkb:Norcuron
|
gptkbp:UNII
|
HCD1DWH53B
|
gptkbp:usedFor
|
facilitation of endotracheal intubation
muscle relaxation during surgery
|
gptkbp:bfsParent
|
gptkb:vecuronium
|
gptkbp:bfsLayer
|
6
|